225 related articles for article (PubMed ID: 11477473)
21. Determination of the CCR2-64I/CCR5-59653T haplotype linkage disequilibrium in a sample of Polish population.
Lewandowska M; Trzeciak WH; Jagodzinski PP
Genetika; 2003 Jun; 39(6):831-3. PubMed ID: 12884524
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
Breunis WB; Biezeveld MH; Geissler J; Kuipers IM; Lam J; Ottenkamp J; Hutchinson A; Welch R; Chanock SJ; Kuijpers TW
Clin Exp Immunol; 2007 Oct; 150(1):83-90. PubMed ID: 17672867
[TBL] [Abstract][Full Text] [Related]
23. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years.
Ortlepp JR; Krantz C; Kimmel M; von Korff A; Vesper K; Schmitz F; Mevissen V; Janssens U; Franke A; Hanrath P; Zerres K; Hoffmann R
Int J Cardiol; 2005 Oct; 105(1):90-5. PubMed ID: 16207551
[TBL] [Abstract][Full Text] [Related]
24. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
[TBL] [Abstract][Full Text] [Related]
25. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
Galimberti D; Fenoglio C; Lovati C; Gatti A; Guidi I; Venturelli E; Cutter GR; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
J Neurol Sci; 2004 Oct; 225(1-2):79-83. PubMed ID: 15465089
[TBL] [Abstract][Full Text] [Related]
26. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
[TBL] [Abstract][Full Text] [Related]
27. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
[TBL] [Abstract][Full Text] [Related]
28. Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population.
Karaali ZE; Sozen S; Yurdum M; Cacina C; Toptas B; Gok O; Agachan B
Mol Biol Rep; 2010 Oct; 37(7):3615-9. PubMed ID: 20182805
[TBL] [Abstract][Full Text] [Related]
29. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.
Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L
Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286
[TBL] [Abstract][Full Text] [Related]
30. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals.
Mazzucchelli R; Corvasce S; Violin M; Riva C; Bianchi R; Dehò L; Velleca R; Cibella J; Bada M; Moroni M; Galli M; Balotta C
J Biol Regul Homeost Agents; 2001; 15(3):265-71. PubMed ID: 11693435
[TBL] [Abstract][Full Text] [Related]
31. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
32. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications.
Yang B; Houlberg K; Millward A; Demaine A
Cytokine; 2004 May; 26(3):114-21. PubMed ID: 15135805
[TBL] [Abstract][Full Text] [Related]
34. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis.
Zapico I; Coto E; Rodríguez A; Alvarez C; Torre JC; Alvarez V
Genes Immun; 2000; 1(4):288-9. PubMed ID: 11196706
[TBL] [Abstract][Full Text] [Related]
35. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
[TBL] [Abstract][Full Text] [Related]
36. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
[TBL] [Abstract][Full Text] [Related]
37. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
[TBL] [Abstract][Full Text] [Related]
38. Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival.
Omrani MD; Mokhtari MR; Tagizadae A; Bagheri M; Ahmad-Poor P
Iran J Immunol; 2008 Dec; 5(4):201-6. PubMed ID: 19098363
[TBL] [Abstract][Full Text] [Related]
39. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.
Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA
Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301
[TBL] [Abstract][Full Text] [Related]
40. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
